 |
 |
||
 |
|||
- Cannabinoid pharmacology: the first 66 years.
Pertwee RG. Br J Pharmacol 2006;147 Suppl 1:S163-71
- Cannabinoids and cancer: pros and cons of an antitumour strategy.
Bifulco M, Laezza C, Pisanti S, Gazzerro P. Br J Pharmacol 2006 Feb [Epub ahead of print]
- Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.
Thomas A, Stevenson LA, Wease KN, et al. Br J Pharmacol. 2005 Dec;146(7):917-26.
updated
12.11.2006 14:57